Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 12:59 pm Purchase | 2025-09-30 | 13G | OKYO Pharma Limited OKYO | Chernett Jorey | 2,984,862 7.800% | 683,562 (+29.70%) | Filing History |
| 2025-11-14 12:50 pm Sale | 2025-09-30 | 13G | OKYO Pharma Limited OKYO | Dauntless Investment Group, LLC | 2,422,048 6.300% | -313,732 (-11.47%) | Filing History |
| 2025-10-29 08:30 am Purchase | 2025-07-22 | 13G | OKYO Pharma Limited OKYO | LAURA NATALIA MONICA FONDA | 1,928,451 5.010% | 1,928,451 (New Position) | Filing History |
| 2025-08-05 3:22 pm Purchase | 2025-06-30 | 13G | OKYO Pharma Limited OKYO | Dauntless Investment Group, LLC | 2,735,780 7.300% | 736,400 (+36.83%) | Filing History |
| 2025-05-27 4:44 pm Purchase | 2025-05-23 | 13G | OKYO Pharma Limited OKYO | Chernett Jorey | 2,301,300 6.800% | 2,301,300 (New Position) | Filing History |
| 2025-03-18 2:35 pm Purchase | 2025-03-12 | 13G | OKYO Pharma Limited OKYO | Dauntless Investment Group, LLC | 1,999,380 5.900% | 1,999,380 (New Position) | Filing History |